The National Institute for Health and Care Excellence (Nice) previously stopped its appraisal of semaglutide (Wegovy) for use ...

President Donald Trump on Monday signed an executive order reviving a controversial plan to lower prescription drug costs by ...

Michael Foote was at dinner with three friends at Soothr, a Thai restaurant in the East Village of Manhattan, when he looked ...

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published ...

Ever since the pharmaceutical company Novo Nordisk realized that GLP-1 drugs were useful for more than diabetes, doctors and ...

Children who are living with severe obesity are more likely to experience a clinically relevant change in BMI when GLP-1 agonist drugs form part of their treatment, new research being presented at ...

New research has shown that Ozempic can cause taste changes in people taking it, even going so far as to make some hate the ...

New data suggests the weight-loss drug Wegovy may significantly reduce the risk of heart disease even before users experience ...

For the first time, scientists have pitted the two most popular weight loss drugs against each other in a direct competition ...

Trump claimed his proposed plan to tie drug prices to those paid in foreign nations would lower by up to 90% the payments by the U.S., although experts said it’s unclear if the plan is legal ...

Experts say weight management drugs have created an unsustainable surge in health care spending, with some insurance ...